Valarie Ikerd, DPM
Podiatrist · Joplin, MONPI 1689600918
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 24 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Kowa Pharmaceuticals America, Inc. at 27.1% of the total. That places this record below the midpoint for podiatrist clinicians in MO, where the typical reported total is $1,070.
Across 24 payments — averaging $17.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kowa Pharmaceuticals America, Inc.$114
- Organogenesis Inc.$53
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$39
- AbbVie$31
- Stryker$29
- Alfasigma USA, Inc.$28
- plus $125 from 7 others
What the payments were for
- Food & beverage$418100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kowa Pharmaceuticals America, Inc. | 7 | $114 |
| Organogenesis Inc. | 3 | $53 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $39 |
| AbbVie | 1 | $31 |
| Stryker | 2 | $29 |
| Alfasigma USA, Inc. | 2 | $28 |
| Davol Inc. | 1 | $25 |
| Titan Surgical Group, LLC | 1 | $20 |
| Averitas Pharma Inc. | 1 | $19 |
| Acera Surgical, Inc. | 1 | $18 |
| Medtronic | 1 | $16 |
| Treace Medical Concepts, Inc. | 1 | $15 |
| Osiris Therapeutics Inc. | 1 | $12 |
How this compares
$418 in reported general payments places this provider in the 30th percentile of 105 podiatrist providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 33 | $354 |
| Cephalexin | 59 | $325 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 16 | $283 |
| Silver Sulfadiazine | 12 | $83 |
| Terbinafine Hcl | 13 | $77 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $45 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Joplin
- Erick StudyvinJoplin$7K
- Brittany CiaramelloJoplin$5K
- William DukeJefferson City$54K
- Kiera Benge-SheaSaint Louis$28K
- Thomas BoldryLiberty$19K
- Ryan FrankIndependence$15K
- Neil ErmitanoSaint Louis$14K
- John HarnessOverland$14K
- Brittany StaplesCreve Coeur$13K
- Daniel NarowitzSaint Louis$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.